These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17486066)

  • 1. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells.
    Berman-Golan D; Elson A
    Oncogene; 2007 Oct; 26(49):7028-37. PubMed ID: 17486066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis.
    Berman-Golan D; Granot-Attas S; Elson A
    Cancer Metastasis Rev; 2008 Jun; 27(2):193-203. PubMed ID: 18231724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.
    Granot-Attas S; Elson A
    Exp Cell Res; 2004 Mar; 294(1):236-43. PubMed ID: 14980517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells.
    Gil-Henn H; Elson A
    J Biol Chem; 2003 May; 278(18):15579-86. PubMed ID: 12598528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Jul; 11(2):271-9. PubMed ID: 7542762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.
    Julien SG; Dubé N; Read M; Penney J; Paquet M; Han Y; Kennedy BP; Muller WJ; Tremblay ML
    Nat Genet; 2007 Mar; 39(3):338-46. PubMed ID: 17259984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transmembranal and cytoplasmic forms of protein tyrosine phosphatase epsilon physically associate with the adaptor molecule Grb2.
    Toledano-Katchalski H; Elson A
    Oncogene; 1999 Sep; 18(36):5024-31. PubMed ID: 10490839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
    Walter AO; Peng ZY; Cartwright CA
    Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.
    Elson A
    Oncogene; 1999 Dec; 18(52):7535-42. PubMed ID: 10602512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: a mediator of osteoclast activity.
    Lau KH; Wu LW; Sheng MH; Amoui M; Suhr SM; Baylink DJ
    J Cell Biochem; 2006 Apr; 97(5):940-55. PubMed ID: 16267838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
    Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
    Karni R; Jove R; Levitzki A
    Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Bentires-Alj M; Neel BG
    Cancer Res; 2007 Mar; 67(6):2420-4. PubMed ID: 17347513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon.
    Peretz A; Gil-Henn H; Sobko A; Shinder V; Attali B; Elson A
    EMBO J; 2000 Aug; 19(15):4036-45. PubMed ID: 10921884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth.
    Bodrikov V; Sytnyk V; Leshchyns'ka I; den Hertog J; Schachner M
    J Cell Biol; 2008 Sep; 182(6):1185-200. PubMed ID: 18809727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.